These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Antithrombotic treatment of NSTEMI/UAP. The interaction with PCI. Otterstad JE; Brosstad F Scand Cardiovasc J; 2004 Mar; 38(1):9-15. PubMed ID: 15204241 [No Abstract] [Full Text] [Related]
31. Efficacy and safety of a routine early invasive strategy after fibrinolysis stratified by glycoprotein IIb/IIIa inhibitor use during percutaneous coronary intervention: a pre-specified subgroup analysis of the TRANSFER-AMI randomised controlled trial. Russo JJ; Goodman SG; Cantor WJ; Fitchett D; Heffernan M; Borgundvaag B; Ducas J; Cohen EA; Džavik V; Mehta SR; Buller CE; Yan AT; Heart; 2014 Jun; 100(11):873-80. PubMed ID: 24449716 [TBL] [Abstract][Full Text] [Related]
32. Fibrinolysis for acute myocardial infarction: the future is here and now. Armstrong PW; Collen D; Antman E Circulation; 2003 May; 107(20):2533-7. PubMed ID: 12777317 [No Abstract] [Full Text] [Related]
33. Fibrinolysis for acute myocardial infarction: current status and new horizons for pharmacological reperfusion, part 1. Armstrong PW; Collen D Circulation; 2001 Jun; 103(23):2862-6. PubMed ID: 11401946 [No Abstract] [Full Text] [Related]
34. Reperfusion therapy for acute myocardial infarction: drugs or devices? Is this the right question? Pavlides GS; Cokkinos DV Clin Cardiol; 2004 May; 27(5):254-6. PubMed ID: 15188937 [No Abstract] [Full Text] [Related]
35. [DC shock and reperfusion in myocardial infarction with ST-segment elevation a hypothesis to be verified]. Pezza B G Ital Cardiol (Rome); 2010 Mar; 11(3):261. PubMed ID: 20550069 [No Abstract] [Full Text] [Related]
36. Role of glycoprotein IIb/IIIa-receptor inhibitors in managing ST-segment-elevation myocardial infarction. Racine E Am J Health Syst Pharm; 2002 Nov; 59(21 Suppl 7):S27-36. PubMed ID: 12434712 [TBL] [Abstract][Full Text] [Related]
37. Pharmacological facilitation of coronary intervention in ST-segment elevation myocardial infarction: time is of the essence. Gersh BJ; Stone GW JACC Cardiovasc Interv; 2010 Dec; 3(12):1292-4. PubMed ID: 21232724 [No Abstract] [Full Text] [Related]
38. Pharmacologic reperfusion therapy for acute myocardial infarction. Lowe HC; Neill BD; Van de Werf F; Jang IK J Thromb Thrombolysis; 2002 Dec; 14(3):179-96. PubMed ID: 12913398 [TBL] [Abstract][Full Text] [Related]
39. Effect of glycoprotein IIb/IIIa receptor blockade on recovery of coronary flow and left ventricular function after the placement of coronary-artery stents in acute myocardial infarction. Neumann FJ; Blasini R; Schmitt C; Alt E; Dirschinger J; Gawaz M; Kastrati A; Schömig A Circulation; 1998 Dec; 98(24):2695-701. PubMed ID: 9851955 [TBL] [Abstract][Full Text] [Related]
40. Direct thrombin inhibitors (part 2 of 2). Arora UK; Dhir M J Invasive Cardiol; 2005 Feb; 17(2):85-91. PubMed ID: 15687531 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]